Rheumatic diseases in women of childbearing years may necessitate drug treatment during
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …

In this review, we summarize our current understanding of the pathophysiology of fragility
fractures that occur for the first time during pregnancy and lactation, and provide guidance …

Glucocorticoids (GCs) are widely used to treat various inflammatory, immunologic, and
allergic disorders that cause rheumatic, respiratory, bowel, hepatic, neurological, renal, and …

Osteoporosis is a global threat because it can impact every human being as they age. In this
new edition, the authors point out the enormous scale of the problem in terms of human …

OBJECTIVE: The unique pharmacokinetics of bisphosphonates (BPs) in conjunction with
their use by an increasing number of women at reproductive age has raised serious …

POP binding. Pyrophosphate was widely employed in industry due to its ability to dissolve
calcium carbonate. Consequently pyrophosphates were used in washing powders and other …

Drugs in the bisphosphonate class are the most commonly prescribed therapeutic agents for
the treatment of osteoporosis. Prospective, randomized, placebo-controlled clinical trials …

Randomized controlled trials have demonstrated the efficacy of bisphosphonates (BP) in
improving BMD and reducing fracture risk. Various safety issues that were not noted in …

Eine ganz entscheidende Rolle in der erfolgreichen Behandlung und Prävention der
Skelettdestruktion in der Osteologie und Onkologie kommt einer neuen Arzneimittelgruppe …

Complex regional pain syndrome (CRPS) remains a challenging clinical pain condition.
Multidisciplinary approaches have been advocated for managing CRPS. Compared with …